The 18 kda translocator protein (peripheral benzodiazepine receptor) expression in the bone of normal, osteoprotegerin or low calcium diet treated mice

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Kam, Winnie Wai Ying ^a,b,c   Meikle, Steven R ^a,b   Dunstan, Colin R ^b   Banati, Richard B ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE RECEPTOR; BIOLOGICAL MARKER; CALCIUM; FLUORINE 18; OSTEOPROTEGERIN; 4 AMINOBUTYRIC ACID RECEPTOR; BZRP PROTEIN, MOUSE; DIAGNOSTIC AGENT; FLUORIDE; FLUORINE; ISOQUINOLINE DERIVATIVE; MESSENGER RNA; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE STRUCTURE; BONE TURNOVER; CALCIUM INTAKE; CONTROLLED STUDY; IMAGING AND DISPLAY; IN VIVO STUDY; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOCLAST; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SIGNAL NOISE RATIO; ANIMAL; ARTIFACT; BONE; CYTOLOGY; DIET; DRUG EFFECT; FEASIBILITY STUDY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; SCINTISCANNING;

ANIMALIA; MUS; RODENTIA;

ANIMALS; ARTIFACTS; BONE AND BONES; CALCIUM; DIET; FEASIBILITY STUDIES; FLUORIDES; FLUORINE RADIOISOTOPES; GENE EXPRESSION REGULATION; HUMANS; ISOQUINOLINES; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOPROTEGERIN; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, GABA; RNA, MESSENGER;

EID: 84856246278     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030623     Document Type: Article

References (40)

1. Braestrup C, Squires RF, (1977) Specific Benzodiazepine Receptors in Rat Brain Characterzied by High-Affinity [3H]diazepam binding. Proc Nat Acad Sci USA 74: 3805-3809.
2. Casellas P, Galiegue S, Basile AS, (2002) Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40: 475-486.
3. De Souza EB, Anholt RR, Murphy KM, Snyder SH, Kuhar MJ, (1985) Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal, and testis. Endocrinology 116: 567-573.
4. Gavish M, Bachman I, Shoukrun R, Katz Y, Veenman L, et al. (1999) Enigma of the Peripheral Benzodiazepine Receptor. Pharmacol Rev 51: 629-650.
5. Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapere J-J, et al. (2006) Translocator protein (18 kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27: 402-409.
6. Banati RB, (2002) Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation? J Physiol Paris 96: 289-299.
7. Banati RB, Myers R, Kreutzberg GW, (1997) PK ('peripheral benzodiazepine')- binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia. J Neurocytol 26: 77-82.
8. Carayon P, Portier M, Dussossoy D, Bord A, Petitpretre G, et al. (1996) Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood 87: 3170-3178.
9. Rosenberg N, Rosenberg O, Leschiner S, Weizman S, Soudry M, et al. (2006) Peripheral Benzodiazepine Receptor (PBR) is identified in human osteoblast. J Bone Joint Surg Br 88-B: 342.
10. Le Fur G, Vaucher N, Perrier ML, Flamier A, Benavides J, et al. (1983) Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]R05-4864 and [3H]PK 11195, by thermodynamic studies. Life Sci 33: 449-457.
11. Le Fur G, Perrier ML, Vaucher N, Imbault F, Flamier A, et al. (1983) Peripheral Benzodiazepine Binding Sites: Effect of PK11195, 1-(2-Chlorophenyl)-N-Methyl-N-(1-Methylpropyl)-3-Isoquinolinecarboxamide. Life Sci 32: 1839-1847.
12. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, et al. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging microglia as a measure of disease activity. Brain 123: 2321-2337.
13. Cagnin A, Myers R, Gunn RN, Lawrence AD, Stevens T, et al. (2001) In vivo visualization of activated glia by [11C](R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain 124: 2014-2027.
14. Gerhard A, Watts J, Trender-Gerhard I, Turkheimer F, Banati RB, et al. (2004) In Vivo Imaging of Microglial Activation With [11C](R)-PK11195 PET in Corticobasal Degeneration. Mov Disord 19: 1221-1226.
15. Wilms H, Claasen J, Röhl C, Sievers J, Deuschl G, et al. (2003) Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro. Neurobiol Dis 14: 417-424.
16. Morony S, Capparelli C, Lee R, Shimamoto G, Boone T, et al. (1999) A Chimeric Form of Osteoprotegerin Inhibits Hypercalcemia and Bone Resorption Induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1,25(OH)2D3. J Bone Miner Res 14: 1478-1485.
17. Zheng Y, Zhou H, Modzelewski JRK, Kalak R, Blair JM, et al. (2007) Accelerated Bone Resorption, Due to Dietary Calcium Deficiency, Promotes Breast Cancer Tumor Growth in Bone. Cancer Res 67: 9542-9548.
18. Giatzakis C, Papadoulos V, (2004) Differential Utilization of the Promotor of Peripheral Type Benzodiazepine Receptor by Steroidogenic Versus Nonsteroidogenic Cell Lines and the Role of Sp1 and Sp3 in the Regulation of Basal Activity. J Endocrinol 145: 113-1123.
19. Kim YJ, Lee MH, Wozney JM, Cho JY, Ryoo HM, (2004) Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by DIx5 and repressed by Msx2. J Biol Chem 279: 50773-50780.
20. Granholm S, Lundberg P, Lerner UH, (2007) Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator NF-kappaB and c-Fms. J Endocrinol 195: 415-427.
21. Dveksler GS, Basile AA, Dieffenbach CW, (1992) Analysis of gene expression: use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase. Genome Res 1: 283-285.
22. Myers R, Manjil LG, Cullen BM, Price GW, Frackowiak RS, et al. (1991) Macrophage and astrocyte populations in relation to [3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab 11: 314-322.
23. Qi J, Leahy RM, Cherry SR, Chatziioannou A, Farquhar TH, (1998) High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. Phys Med Biol 43: 1001-1013.
24. Woodard HQ, Bigler RE, Freed B, Russ G, (1975) Expression of Tissue Isotope Distribution. J Nucl Med 16: 958-959.
25. Ruff MR, Pert CB, Weber RJ, Wahl LM, Wahl SM, et al. (1985) Benzodiazepine Receptor-Mediated Chemotaxis of Human Monocytes. Science 229: 1281-1283.
26. Canat X, Carayon P, Bouaboula M, Cahard D, Shire D, et al. (1992) Distribution Profile and Properties of Peripheral-Type Benzodiazepine Receptor on Human Hemopoietic Cells. Life Sci 52: 107-118.
27. Berkovich A, Ferrarese C, Cavaletti G, Alho H, Marzorati C, et al. (1993) Topology of two DBI receptors in human lymphocytes. Life Sci 52: 1265-1277.
28. Benavides J, Quarteronet D, Plouin P-F, Imbault F, Phan T, et al. (1984) Characterization of peripheral type benzodiazepine binding sites in human and rat platelets by using [3H]PK 11195. Studies in hypertensive patients. Biochem Pharmacol 33: 2467-2472.
29. Olson JMM, Ciliax BJ, Mancini WR, Young AB, (1988) Presence of peripheral-type benzodiazepine binding sites on human erythrocyte membranes. Eur J Pharmacol 152: 47-53.
30. Miltyk W, Pałka M, Karna E, Jarza{ogonek}bek K, Boujrad N, et al. (2006) Antimitotic activity of high affinity ligands for peripheral benzodiazepine receptor (PBR) in some normal and neoplastic cell lines. Adv Med Sci 51: 156-159.
31. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, et al. (1997) Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density. Cell 89: 309-319.
32. Owen DRJ, Gunn RN, Rabiner EA, Bennacef I, Fujita M, et al. (2011) Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands. Journal of Nuclear Medicine 52: 24-32.
33. Duan Y, Tabensky A, DeLuca V, Seeman E, (1997) The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur. Bone 21: 447-451.
34. Bianco P, Gehron Robey P, (2000) Marrow stromal stem cells. J Clin Invest 105: 1663-1668.
35. Penney JB, Frey K, Young AB, (1981) Quantitative autoradiography of neurotransmitter receptors using tritium-sensitive film. Eur J Pharmacol 72: 421-422.
36. Brenner W, Vernon C, Muzi M, Mankoff DA, Link JM, et al. (2004) Comparison of different quantitative approaches to F-18-fluoride PET scans. J Nucl Med 45: 1493-1500.
37. Lin KP, Huang SC, Choi Y, Brunken RC, Schelbert HR, et al. (1995) Correction of Spillover Radioactivities for Estimation of the Blood Time-Activity Curve from the Imaged LV Chamber in Cardiac Dynamic FDG PET Studies. Phys Med Biol 40: 629-642.
38. Hoffman E, Huang S-C, Phelps ME, (1979) Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size. J Comput Assist Tomogr 3: 299-308.
39. Nothdurfter C, Rammes G, Baghai TC, Schüle C, Schumacher M, et al. (2011) TSPO (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile. J Neuroendocrinol doi:10.1111/j.1365-2826.2011.02166.x.
40. Schüle C, Eser D, Baghai TC, Nothdurfter C, Kessler JS, et al. (2011) Neuroactive steroids in affective disorders: target for novel antidepressant or anxiolytic drugs? Neuroscience doi:10.1016/j.neuroscience.2011.03.025.